Home/ economie ECONOMIEChina Approves First Oral GLP-1 Anti-Obesity Drug by Eli LillyThe U.S. pharmaceutical company has become the first to receive Chinese approval for an oral GLP-1-based anti-obesity treatment.Published 1h·1 sourceNotable Lire en françaisListen≈ 11sSpeed0.8×1×1.2×1.5×🔗Click the link to read an article on the topic:BFM Biz↗🧭Explore this topicChineEli Lilly#Eli Lilly#Chine#traitement anti-obésité#GLP-1#pharmacie#santéWhat if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→Chine · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →Follow topic →↗ Share the newsAuto-synthesis from 1 media source · identified on November 12, 2026← Back to home